Steven R. Fox
Directeur Général chez Stalar 1, Inc.
Profil
Steven R.
Fox is the founder and currently holds the position of Chairman at Akelos, Inc. which was founded in 2018.
He is also currently serving as the Chief Executive Officer at Stalar 1, Inc., Stalar 2, Inc., and Chairman at The Rebel Group, Inc. since 2000.
Additionally, he is a Member at The American College of Financial Services and the International College of Dentists.
In his former positions, Dr. Fox served as the Chairman, Chief Executive Officer & CFO at Enamelon, Inc. from 1992 to 2000.
He also held executive roles at Stalar 3, Inc., Stalar 4, Inc., and Stalar 5, Inc. as President, CEO, CFO, Secretary, and Director.
Furthermore, he served as an Independent Director at Paltalk, Inc. and as a Faculty Member at Harvard University.
He briefly worked as an Analyst at Opus Group Financial in 2012.
Dr. Fox completed his undergraduate degree at Rochester Christian University in 1975 and obtained his doctorate degree from New York University in 1978.
Postes actifs de Steven R. Fox
| Sociétés | Poste | Début |
|---|---|---|
Stalar 1, Inc.
 Stalar 1, Inc. Financial ConglomeratesFinance Stalar 1, Inc. engages in the operations of a development stage company. The company was founded on November 13, 2007 and is headquartered in New York, NY. | Directeur Général | - |
Stalar 2, Inc.
 Stalar 2, Inc. Financial ConglomeratesFinance Stalar 2, Inc. operates as a developing stage company. Its business purpose is to seek the acquisition of, or merger with, an existing operating firm. The company was founded on November 13, 2007 and is headquartered in New York, NY. | Directeur Général | - |
| The American College of Financial Services | Corporate Officer/Principal | 28/12/2009 |
| International College of Dentists | Corporate Officer/Principal | 28/12/2009 |
| The Rebel Group, Inc. /NY/ | Président | 23/03/2011 |
Akelos, Inc.
 Akelos, Inc. Pharmaceuticals: MajorHealth Technology Akelos, Inc. operates as a biopharmaceutical clinical company, developing novel non-narcotic drugs for the treatment of neuropathic pain. The company was founded by Steven R. Fox in 2018 and is headquartered in New York, NY. | Fondateur | 01/01/2018 |
Anciens postes connus de Steven R. Fox
| Sociétés | Poste | Fin |
|---|---|---|
Stalar 4, Inc.
 Stalar 4, Inc. Financial ConglomeratesFinance Stalar 4, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private foreign or domestic company that is seeking to become a reporting public company. Stalar 4 was founded on November 13, 2007 and is headquartered in New York, NY. | Directeur Financier/CFO | 09/12/2009 |
Stalar 3, Inc.
 Stalar 3, Inc. Financial ConglomeratesFinance Stalar 3, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private company, foreign & domestic, seeking to become a public company. The firm has been engaged in initial financing and has commenced negotiations with operating entities. It was founded on November 13, 2007 and is headquartered in New York, NY. | Directeur Financier/CFO | 09/12/2009 |
Enamelon, Inc.
 Enamelon, Inc. Household/Personal CareConsumer Non-Durables Enamelon, Inc. engages in developing oral care products. The company was founded in June 1992 and is headquartered in Cranbury, NJ. | Président | 31/12/2000 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Steven R. Fox
| Rochester Christian University | Undergraduate Degree |
| New York University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PALTALK, INC. | Technology Services |
| Entreprise privées | 10 |
|---|---|
Enamelon, Inc.
Enamelon, Inc. Household/Personal CareConsumer Non-Durables Enamelon, Inc. engages in developing oral care products. The company was founded in June 1992 and is headquartered in Cranbury, NJ. | Consumer Non-Durables |
Stalar 1, Inc.
Stalar 1, Inc. Financial ConglomeratesFinance Stalar 1, Inc. engages in the operations of a development stage company. The company was founded on November 13, 2007 and is headquartered in New York, NY. | Finance |
Stalar 2, Inc.
Stalar 2, Inc. Financial ConglomeratesFinance Stalar 2, Inc. operates as a developing stage company. Its business purpose is to seek the acquisition of, or merger with, an existing operating firm. The company was founded on November 13, 2007 and is headquartered in New York, NY. | Finance |
Stalar 3, Inc.
Stalar 3, Inc. Financial ConglomeratesFinance Stalar 3, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private company, foreign & domestic, seeking to become a public company. The firm has been engaged in initial financing and has commenced negotiations with operating entities. It was founded on November 13, 2007 and is headquartered in New York, NY. | Finance |
Stalar 4, Inc.
Stalar 4, Inc. Financial ConglomeratesFinance Stalar 4, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private foreign or domestic company that is seeking to become a reporting public company. Stalar 4 was founded on November 13, 2007 and is headquartered in New York, NY. | Finance |
Stalar 5, Inc.
 Stalar 5, Inc. Financial ConglomeratesFinance Stalar 5, Inc. operated as a development stage company. It was formed as a vehicle to pursue a business combination and identify possible business combinations. The firm's purpose is to seek the acquisition of or merger with, an existing company. The company was founded in 2012 and was headquartered in New York, NY. | Finance |
| International College of Dentists | |
Opus Group Financial
 Opus Group Financial Investment ManagersFinance Founded in 2010 by James Giordano, Opus Group Financial is an independent, privately-owned, investment research and advisory firm located in New York City with an additional office in Ft. Lauderdale, Florida. The firm provides in-depth, unbiased, equity research, financial advice and execution services to private, micro- and small-cap companies | Finance |
| The Rebel Group, Inc. /NY/ | |
Akelos, Inc.
Akelos, Inc. Pharmaceuticals: MajorHealth Technology Akelos, Inc. operates as a biopharmaceutical clinical company, developing novel non-narcotic drugs for the treatment of neuropathic pain. The company was founded by Steven R. Fox in 2018 and is headquartered in New York, NY. | Health Technology |
